133.60
-5.61 (-4.03%)
| Penutupan Terdahulu | 139.21 |
| Jumlah Dagangan | 24,768 |
| Harga / Jualan (P/S) | 3.07 |
| Harga / Buku (P/B) | 3.94 |
| Julat 52 Minggu | |
| Hasil Dividen (DY TTM) | 0.48% |
| Margin Keuntungan | -0.82% |
| Margin Operasi (TTM) | 2.36% |
| EPS Cair (TTM) | -0.360 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 121.29% |
| Nisbah Semasa (MRQ) | 0.630 |
| Aliran Tunai Operasi (OCF TTM) | 46.81 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 60.43 M |
| Pulangan Atas Aset (ROA TTM) | 2.49% |
| Pulangan Atas Ekuiti (ROE TTM) | -1.29% |
Sentimen Berita
AISkor Stockmoo
| Nilai 38% | -1.7 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -1.7 |
| Masa 38% | 0.2 |
| AI Technical info | NA |
| Osilator Teknikal info | 2.0 |
| Purata Bergerak Teknikal info | -2.5 |
| Sentimen 25% | 0.4 |
| Konsensus Penganalisis info | 0.0 |
| Sentimen Berita info | 1.4 |
| Wang Pintar | NA |
| Aktiviti Orang Dalam info | NA |
| Aliran Institusi info | NA |
| Kedudukan Jual Singkat info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -20.1% |
| Persetujuan Tonggak | ×1.00 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -5.0 |
| Skor Akhir | -0.55 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Scientific & Technical Instruments (US) | Bercampur | Menaik |
| Scientific & Technical Instruments (Global) | Bercampur | Menaik | |
| Stok | Mesa Laboratories, Inc. | Bercampur | Menaik |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| MLAB | - | 0.48% | - | 3.94 |
| MIND | - | - | - | 0.700 |
| FCUV | - | - | - | 0.280 |
| WRAP | - | - | - | 5.19 |
| SVRE | - | - | - | 0.370 |
| ASTC | - | - | - | 0.520 |
|
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products. |
|
| Sektor | Technology |
| Industri | Scientific & Technical Instruments |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 5.12% |
| % Dimiliki oleh Institusi | 95.68% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Nov 2026 | Yahoo Finance |
Sterilization Monitoring Technologies - Global Strategic Business Report 2026: Secure Share of the $1 Billion Market by 2032 | Features Competitive Intelligence on 3M, Steris, Getinge, Cardinal Health and Mesa Laboratories
Smart, wireless and cloud-based monitoring improves accuracy, automates compliance, reduces errors and streamlines sterilization workflows across healthcare settingsDublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "Sterilization Monitoring Technologies - Global Strategic Business Report 2026" has been… |
| 10 Nov 2026 | Yahoo Finance |
Mesa Laboratories Inc (MLAB) Q2 2027 Earnings Call Highlights: Margin Expansion and ...
Mesa Laboratories Inc (MLAB) posted 2.6% organic revenue growth with adjusted EBITDA up 21.1%, while restructuring clinical genomics and resolving a key SDC product line remain top priorities. |
| 09 Nov 2026 | Yahoo Finance |
Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance
LAKEWOOD, Colo., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced results for its second fiscal quarter (“2Q27”) ended… |
| 09 Nov 2026 | Yahoo Finance |
Mesa Labs: Fiscal Q2 Earnings Snapshot
(MLAB) on Monday reported net income of $4.3 million in its fiscal second quarter. |
| 09 Nov 2026 | Yahoo Finance |
What Mesa Laboratories (MLAB) Said on Its Q2 Earnings Call
Mesa Laboratories (NASDAQ:MLAB) reported higher revenue and earnings for its fiscal 2027 second quarter and issued full-year guidance, while outlining plans to restructure its Clinical Genomics business and repurchase up to $40 million in shares. The company expects fiscal 2027 revenue of $250 mill… |
| 09 Nov 2026 | Yahoo Finance |
Mesa Labs (MLAB) Q2 2027 Earnings Call Transcript
Debt paydown and a new buyback shape a quarter with mixed segment results. |
| 09 Nov 2026 | Yahoo Finance |
Mesa Laboratories, Inc. Q2 2027 Earnings Call Summary
Moby summary of Mesa Laboratories, Inc.'s Q2 2027 earnings call… |
| 28 Oct 2026 | Yahoo Finance |
Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced it will release financial results for its… |
| 13 Oct 2026 | Yahoo Finance |
Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
The Restructuring Program focuses Clinical Genomics on profitability and adds resources in Sterilization and Disinfection Control, Calibration Solutions and AsiaLAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa,” “we,” “us” or “our”), a global leader… |
| 09 Oct 2026 | Yahoo Finance |
MESA LABS DECLARES QUARTERLY DIVIDEND
Lakewood, Colo., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on December 15… |
| 17 Aug 2026 | Yahoo Finance |
Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript
CEO Kadia highlights execution fixes and debt reduction amid SDC fulfillment challenges. |
| Papar semua | ||
| Hasil Dividen (DY TTM) | 0.48% |
| Purata Hasil Dividen 5T | 0.50% |
| Nisbah Pembayaran | 376.47% |
| Jangkaan Pembayaran Dividen Seterusnya | Mar 2027 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 30 Nov 2026 | 08 Oct 2026 | 15 Dec 2026 | 0.16 Tunai |
| 31 Aug 2026 | 06 Jul 2026 | 15 Sep 2026 | 0.16 Tunai |
| 29 May 2026 | 02 Apr 2026 | 15 Jun 2026 | 0.16 Tunai |
| 27 Feb 2026 | 06 Jan 2026 | 16 Mar 2026 | 0.16 Tunai |
| 28 Nov 2025 | 03 Oct 2025 | 15 Dec 2025 | 0.16 Tunai |
| 29 Aug 2025 | 03 Jul 2025 | 15 Sep 2025 | 0.16 Tunai |
| 30 May 2025 | 07 Apr 2025 | 16 Jun 2025 | 0.16 Tunai |
| 28 Feb 2025 | 06 Jan 2025 | 17 Mar 2025 | 0.16 Tunai |
| 29 Nov 2024 | 02 Oct 2024 | 16 Dec 2024 | 0.16 Tunai |
| 30 Aug 2024 | 08 Jul 2024 | 16 Sep 2024 | 0.16 Tunai |
| 31 May 2024 | 02 Apr 2024 | 14 Jun 2024 | 0.16 Tunai |
| 28 Feb 2024 | 02 Jan 2024 | 15 Mar 2024 | 0.16 Tunai |
| 29 Nov 2023 | 02 Oct 2023 | 15 Dec 2023 | 0.16 Tunai |
| 30 Aug 2023 | 05 Jul 2023 | 15 Sep 2023 | 0.16 Tunai |
| 30 May 2023 | 03 Apr 2023 | 15 Jun 2023 | 0.16 Tunai |
| 27 Feb 2023 | 03 Jan 2023 | 15 Mar 2023 | 0.16 Tunai |
| 29 Nov 2022 | 03 Oct 2022 | 15 Dec 2022 | 0.16 Tunai |
| 30 Aug 2022 | 06 Jul 2022 | 15 Sep 2022 | 0.16 Tunai |
| 27 May 2022 | 04 Apr 2022 | 15 Jun 2022 | 0.16 Tunai |
| 25 Feb 2022 | 05 Jan 2022 | 15 Mar 2022 | 0.16 Tunai |
| 29 Nov 2021 | 01 Oct 2021 | 15 Dec 2021 | 0.16 Tunai |
| 30 Aug 2021 | 06 Jul 2021 | 15 Sep 2021 | 0.16 Tunai |
| 27 May 2021 | 05 Apr 2021 | 15 Jun 2021 | 0.16 Tunai |
| 25 Feb 2021 | 04 Jan 2021 | 15 Mar 2021 | 0.16 Tunai |
| 27 Nov 2020 | 01 Oct 2020 | 15 Dec 2020 | 0.16 Tunai |
| 28 Aug 2020 | 03 Jul 2020 | 15 Sep 2020 | 0.16 Tunai |
| 28 May 2020 | 01 Apr 2020 | 15 Jun 2020 | 0.16 Tunai |
| 27 Feb 2020 | 08 Jan 2020 | 16 Mar 2020 | 0.16 Tunai |
| 27 Nov 2019 | 01 Oct 2019 | 16 Dec 2019 | 0.16 Tunai |
| 29 Aug 2019 | 08 Jul 2019 | 16 Sep 2019 | 0.16 Tunai |
| 30 May 2019 | 08 Apr 2019 | 14 Jun 2019 | 0.16 Tunai |
| 27 Feb 2019 | 02 Jan 2019 | 15 Mar 2019 | 0.16 Tunai |
| 29 Nov 2018 | 01 Oct 2018 | 17 Dec 2018 | 0.16 Tunai |
| 30 Aug 2018 | 05 Jul 2018 | 17 Sep 2018 | 0.16 Tunai |
| 30 May 2018 | 03 Apr 2018 | 15 Jun 2018 | 0.16 Tunai |
| 27 Feb 2018 | 02 Jan 2018 | 15 Mar 2018 | 0.16 Tunai |
| 29 Nov 2017 | 02 Oct 2017 | 15 Dec 2017 | 0.16 Tunai |
| 29 Aug 2017 | 05 Jul 2017 | 15 Sep 2017 | 0.16 Tunai |
| 26 May 2017 | 05 Apr 2017 | 15 Jun 2017 | 0.16 Tunai |
| 24 Feb 2017 | 03 Jan 2017 | 15 Mar 2017 | 0.16 Tunai |
| 28 Nov 2016 | 03 Oct 2016 | 15 Dec 2016 | 0.16 Tunai |
| 29 Aug 2016 | 05 Jul 2016 | 15 Sep 2016 | 0.16 Tunai |
| 26 May 2016 | 11 Apr 2016 | 15 Jun 2016 | 0.16 Tunai |
| 25 Feb 2016 | 05 Jan 2016 | 15 Mar 2016 | 0.16 Tunai |
| 25 Nov 2015 | 01 Oct 2015 | 15 Dec 2015 | 0.16 Tunai |
| 27 Aug 2015 | 07 Jul 2015 | 15 Sep 2015 | 0.16 Tunai |
| 27 May 2015 | 01 Apr 2015 | 15 Jun 2015 | 0.16 Tunai |
| 25 Feb 2015 | 06 Jan 2015 | 16 Mar 2015 | 0.16 Tunai |
| 25 Nov 2014 | 02 Oct 2014 | 15 Dec 2014 | 0.16 Tunai |
| 27 Aug 2014 | 16 Jul 2014 | 15 Sep 2014 | 0.15 Tunai |
| 28 May 2014 | 23 Apr 2014 | 16 Jun 2014 | 0.15 Tunai |
| 26 Feb 2014 | 31 Jan 2014 | 17 Mar 2014 | 0.15 Tunai |
| 26 Nov 2013 | 31 Oct 2013 | 16 Dec 2013 | 0.15 Tunai |
| 28 Aug 2013 | 05 Aug 2013 | 18 Sep 2013 | 0.14 Tunai |
| 25 Feb 2013 | 05 Feb 2013 | 15 Mar 2013 | 0.14 Tunai |
| Papar semua | |||
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2026 | 0.640 | 4 | 0.48 |
| 2025 | 0.640 | 4 | 0.82 |
| 2024 | 0.640 | 4 | 0.49 |
| 2023 | 0.640 | 4 | 0.61 |
| 2022 | 0.640 | 4 | 0.39 |
| 2021 | 0.640 | 4 | 0.20 |
| 2020 | 0.640 | 4 | 0.22 |
| 2019 | 0.640 | 4 | 0.26 |
| 2018 | 0.640 | 4 | 0.31 |
| 2017 | 0.640 | 4 | 0.52 |
| 2016 | 0.640 | 4 | 0.52 |
| 2015 | 0.640 | 4 | 0.64 |
| 2014 | 0.610 | 4 | 0.79 |
| 2013 | 0.430 | 3 | 0.55 |
| Papar semua | |||
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |